AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 APR 10 - (NewsRx.com & NewsRx.net) -- Reproductive Medicine Associates of New Jersey (RMA NJ), a fertility center, is beginning a clinical study to test a new technique that may improve pregnancy rates in women undergoing in vitro fertilization (IVF).
The study also aims to reduce miscarriages and inherited disorders in offspring.
"This study is one of the first to combine two recent advances in infertility treatment - preimplantation genetic diagnosis, or PGD, and blastocyst transfer - to increase the chances of successful pregnancy with low multiple births, using the fewest, healthiest embryos," said Richard Scott, MD, a nationally esteemed reproductive endocrinologist, who pioneered and directs the study at RMA NJ. "If results are favorable, we will have discovered an important advance in IVF treatment that will give couples a greater chance to achieve parenthood with the delivery of a genetically healthy baby."
In the RMA NJ randomized study, 120 patients under age 38 will undergo IVF to produce multiple eggs, using a fertility medication known as Bravelle (urofollitropin for injection, USP), a highly purified, human-derived follicle-stimulating hormone. The resulting eggs will be collected in a traditional manner and then fertilized in the lab.
After 3 days in the lab, the resulting embryos will be tested with a new state-of-the-art technology, preimplantation genetic, which tests each embryo for genetic disorders. PGD involves removing one of the approximately eight cells in each embryo and testing it for ...
Source: HighBeam Research, Study begins of technique to increase chances of pregnancy in IVF.(in...